Privia Health Group, Inc. PRVA
21.47 USD +0.19 (+0.89%)
At closeNov 3, 2026, 4:06 PM EST
21.47 0.00 0.00%
After hours · Nov 3, 4:06 PM ET
21.17 Day range 21.79
18.92 52-week range 28.82
- YTD
- -9.45%
- 1 year
- -13.29%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 31.47 +46.6% upside
Now 21.47
- Target (low)
- 24.00
- Target (mean)
- 31.47
- Target (high)
- 40.00
Ratings (0m) 18 17 buy · 1 hold · 0 sell
- Strong buy5
- Buy12
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 18
- 1 month ago 18
- 2 months ago 19
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.238 | 0.18 – 0.32 | 0.29 | -17.9% | 610.62M | +5.2% | 10 |
| Next quarter | 0.246 | 0.18 – 0.33 | 0.25 | -1.6% | 611.30M | +13.0% | 10 |
| Current year | 0.887 | 0.77 – 1.24 | 0.99 | -10.4% | 2.46B | +15.8% | 10 |
| Next year | 1.06 | 0.85 – 1.36 | 0.887 | +19.8% | 2.70B | +9.7% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 26, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 8, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Mar 25, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Mar 3, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 2, 2026 | Truist Securities | Maintained | Buy | Buy |
| Feb 27, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 4, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Nov 13, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 13, 2025 | BMO Capital | Initiated | — | Outperform |
| Nov 12, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 10, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Nov 10, 2025 | Truist Securities | Reiterated | Buy | Buy |
| Nov 7, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Nov 7, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Oct 9, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Sep 24, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Sep 4, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Aug 29, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Aug 11, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 9, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| May 28, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| May 27, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 28, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 15, 2025 | Baird | Maintained | Outperform | Outperform |
| Apr 10, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 10, 2025 | Truist Securities | Maintained | Buy | Buy |
| Apr 10, 2025 | Needham | Reiterated | Buy | Buy |
| Mar 21, 2025 | Needham | Reiterated | Buy | Buy |
| Feb 28, 2025 | Citizens Capital Markets | Maintained | Market Outperform | Market Outperform |
